-+ 0.00%
-+ 0.00%
-+ 0.00%

KAZIA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PNOC035 CLINICAL STUDY EVALUATING PAXALISIB FOR RECURRENT PEDIATRIC AT/RT BRAIN CANCER

路透·09/09/2026 11:30:01

登錄查看新聞詳情